Tea Lanišnik Rižner - Search Results

Year	Number of Results
2003	4
2004	2
2005	10
2006	9
2007	5
2008	10
2009	9
2010	2
2011	9
2012	15
2013	11
2014	11
2015	11
2016	6
2017	9
2018	7
2019	6
2020	5
2021	10
2022	9
2023	10
2024	1

1

Maser E, Lanišnik Rižner T. Maser E, et al. Among authors: lanisnik rizner t. J Steroid Biochem Mol Biol. 2012 Mar;129(1-2):1-3. doi: 10.1016/j.jsbmb.2012.01.002. Epub 2012 Jan 11. J Steroid Biochem Mol Biol. 2012. PMID: 22381541 No abstract available.

2

Aldo-Keto Reductases and Cancer Drug Resistance.

Penning TM, Jonnalagadda S, Trippier PC, Rižner TL. Penning TM, et al. Among authors: rizner tl. Pharmacol Rev. 2021 Jul;73(3):1150-1171. doi: 10.1124/pharmrev.120.000122. Pharmacol Rev. 2021. PMID: 34312303 Free PMC article. Review.

3

Integration of androgen hormones in endometrial cancer biology.

Gjorgoska M, Rizner TL. Gjorgoska M, et al. Among authors: rizner tl. Trends Endocrinol Metab. 2022 Sep;33(9):639-651. doi: 10.1016/j.tem.2022.06.001. Epub 2022 Jul 22. Trends Endocrinol Metab. 2022. PMID: 35879182 Free article. Review.

4

TGFBI as a candidate biomarker for non-invasive diagnosis of early-stage endometriosis.

Janša V, Pušić Novak M, Ban Frangež H, Rižner TL. Janša V, et al. Among authors: rizner tl. Hum Reprod. 2023 Jul 5;38(7):1284-1296. doi: 10.1093/humrep/dead091. Hum Reprod. 2023. PMID: 37187159 Free PMC article.

5

Targeting the formation of estrogens for treatment of hormone dependent diseases-current status.

Rižner TL, Romano A. Rižner TL, et al. Front Pharmacol. 2023 Apr 28;14:1155558. doi: 10.3389/fphar.2023.1155558. eCollection 2023. Front Pharmacol. 2023. PMID: 37188267 Free PMC article. Review.

6

Steroid-transforming enzymes in fungi.

Kristan K, Rižner TL. Kristan K, et al. Among authors: rizner tl. J Steroid Biochem Mol Biol. 2012 Mar;129(1-2):79-91. doi: 10.1016/j.jsbmb.2011.08.012. Epub 2011 Sep 14. J Steroid Biochem Mol Biol. 2012. PMID: 21946531 Review.

7

Editorial: Women in experimental pharmacology and drug discovery: 2021.

Rižner TL, Özvegy-Laczka C. Rižner TL, et al. Front Pharmacol. 2022 Nov 9;13:1077670. doi: 10.3389/fphar.2022.1077670. eCollection 2022. Front Pharmacol. 2022. PMID: 36438834 Free PMC article. No abstract available.

8

Endometrial cancer diagnostic and prognostic algorithms based on proteomics, metabolomics, and clinical data: a systematic review.

Romano A, Rižner TL, Werner HMJ, Semczuk A, Lowy C, Schröder C, Griesbeck A, Adamski J, Fishman D, Tokarz J. Romano A, et al. Among authors: rizner tl. Front Oncol. 2023 Apr 6;13:1120178. doi: 10.3389/fonc.2023.1120178. eCollection 2023. Front Oncol. 2023. PMID: 37091170 Free PMC article. Review.

9

Editorial: Translational research for better diagnosis and treatment of endometrial cancer.

Romano A, Semczuk A, Tokarz J, Rižner TL. Romano A, et al. Among authors: rizner tl. Front Oncol. 2023 Oct 19;13:1305140. doi: 10.3389/fonc.2023.1305140. eCollection 2023. Front Oncol. 2023. PMID: 37927477 Free PMC article. No abstract available.

10

Estrogens and the Schrödinger's Cat in the Ovarian Tumor Microenvironment.

Gjorgoska M, Rižner TL. Gjorgoska M, et al. Among authors: rizner tl. Cancers (Basel). 2021 Oct 6;13(19):5011. doi: 10.3390/cancers13195011. Cancers (Basel). 2021. PMID: 34638494 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

133 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

133 results

Results by year